| Lastest Insider Transactions Of Syros Pharmaceuticals, Inc. ( SYRS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2024-04-03 | Sell | 10,451 | 4.95 | 51,732 | 2024-04-05 16:30:08 |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | 2024-03-31 | Option Exercise | 13,666 | 0.00 | 0 | 2024-04-02 17:01:57 |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | Directior | 2024-03-31 | Option Exercise | 45,566 | 0.00 | 0 | 2024-04-02 16:59:57 |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2024-03-31 | Sell | 150 | 4.98 | 747 | 2024-04-02 16:58:50 |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2024-03-31 | Option Exercise | 15,333 | 0.00 | 0 | 2024-04-02 16:58:50 |
| SYRS | Syros Pharmaceuticals, Inc. | Quirk Gerald E | Chief Legal & Compliance Offic | 2024-03-27 | Option Exercise | 22,500 | 0.00 | 0 | 2024-04-02 16:57:04 |
| SYRS | Syros Pharmaceuticals, Inc. | Haas Jason | Chief Financial Officer | 2024-03-31 | Option Exercise | 15,333 | 0.00 | 0 | 2024-04-02 16:54:49 |
| SYRS | Syros Pharmaceuticals, Inc. | Chee Conley | President & CEO | 2024-03-31 | Option Exercise | 13,666 | 0.00 | 0 | 2024-04-02 16:52:51 |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Directior | 2023-12-21 | Buy | 904,977 | 4.42 | 3,999,998 | 2023-12-26 17:24:30 |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2023-12-12 | Sell | 6,287 | 4.95 | 31,121 | 2023-12-14 16:24:05 |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2023-12-06 | Sell | 6,287 | 3.95 | 24,834 | 2023-12-08 16:23:31 |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | 2023-10-31 | Option Exercise | 40,125 | 0.00 | 0 | 2023-11-02 16:54:12 |
| SYRS | Syros Pharmaceuticals, Inc. | Haas Jason | Chief Financial Officer | 2023-10-31 | Option Exercise | 18,875 | 0.00 | 0 | 2023-11-02 16:53:32 |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2023-10-31 | Option Exercise | 18,875 | 0.00 | 0 | 2023-11-02 16:52:48 |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | 2023-10-31 | Option Exercise | 17,000 | 0.00 | 0 | 2023-11-02 16:52:15 |
| SYRS | Syros Pharmaceuticals, Inc. | Chee Conley | Chief Commercial Officer | 2023-10-31 | Option Exercise | 17,000 | 0.00 | 0 | 2023-11-02 16:51:17 |
| SYRS | Syros Pharmaceuticals, Inc. | Quirk Gerald E | Chief Legal & Compliance Offic | 2023-10-11 | Option Exercise | 22,500 | 0.00 | 0 | 2023-10-20 16:23:25 |
| SYRS | Syros Pharmaceuticals, Inc. | Young Richard A | Directior | 2023-09-16 | Option Exercise | 2,666 | 0.00 | 0 | 2023-09-19 16:48:15 |
| SYRS | Syros Pharmaceuticals, Inc. | Alles Mark J | Directior | 2023-09-16 | Option Exercise | 2,666 | 0.00 | 0 | 2023-09-19 16:47:30 |
| SYRS | Syros Pharmaceuticals, Inc. | AKKARAJU SRINIVAS | Directior | 2023-09-16 | Option Exercise | 2,666 | 0.00 | 0 | 2023-09-19 16:46:51 |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2023-07-31 | Sell | 7,348 | 3.95 | 29,025 | 2023-08-02 16:21:57 |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | 2023-07-17 | Sell | 689 | 3.50 | 2,412 | 2023-07-18 20:27:08 |
| SYRS | Syros Pharmaceuticals, Inc. | Haas Jason | Chief Financial Officer | 2023-03-31 | Option Exercise | 2,000 | 0.00 | 0 | 2023-04-04 18:57:29 |
| SYRS | Syros Pharmaceuticals, Inc. | Chee Conley | Chief Commercial Officer | 2023-03-31 | Option Exercise | 2,000 | 0.00 | 0 | 2023-04-04 18:56:43 |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | 2023-03-31 | Option Exercise | 2,000 | 0.00 | 0 | 2023-04-04 18:56:06 |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | 2023-03-31 | Option Exercise | 2,000 | 0.00 | 0 | 2023-04-04 18:55:19 |
| SYRS | Syros Pharmaceuticals, Inc. | Olson Eric R | Chief Scientific Officer | 2023-03-31 | Option Exercise | 2,000 | 0.00 | 0 | 2023-04-04 18:54:39 |
| SYRS | Syros Pharmaceuticals, Inc. | Simonian Nancy A | President & CEO | 2023-03-31 | Option Exercise | 6,000 | 0.00 | 0 | 2023-04-04 18:54:18 |
